Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells (Q30319956)

17 June 2017

title

Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells (English)

1 reference

17 June 2017

1 reference

Patzer L

1

1 reference

17 June 2017

Hernando N

2

1 reference

17 June 2017

Ziegler U

3

1 reference

17 June 2017

Beck-Schimmer B

4

1 reference

17 June 2017

Biber J

5

1 reference

17 June 2017

Murer H

6

1 reference

17 June 2017

language of work or name

English

0 references

publication date

27 September 2006

1 reference

17 June 2017

1 reference

17 June 2017

volume

70

1 reference

17 June 2017

issue

10

1 reference

17 June 2017

page(s)

1725-1734

1 reference

Renal involvement in children with malignancies

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Nephrotoxicity of ifosfamide--moving towards understanding the molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Use of mesna to prevent ifosfamide-induced urotoxicity

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Toxicity of chloroacetaldehyde is similar in adult and pediatric kidney tubules

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

X-linked hypercalciuric nephrolithiasis: Clinical syndromes and chloride channel mutations

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

A common molecular basis for three inherited kidney stone diseases

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

An internalization signal in ClC-5, an endosomal Cl-channel mutated in dent's disease.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Proximal tubular phosphate reabsorption: molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Regulation of Na/Pi transporter in the proximal tubule

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/P i cotransporter

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Dechloroethylation of ifosfamide and neurotoxicity

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Population pharmacokinetics of ifosfamide and its 2- and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

A phase II study of ifosfamide in children with recurrent solid tumours

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Cyclophosphamide metabolism in children following a 1-h and a 24-h infusion.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Molecular mechanisms of chloroacetaldehyde-induced cytotoxicity in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Differential cytotoxicity of Ifosfamide and its metabolites in renal epithelial cell cultures

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Activated oxazaphosphorines are transported predominantly by erythrocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Bisubstrates: substances that interact with both, renal contraluminal organic anion and organic cation transport systems. II. Zwitterionic substrates: dipeptides, cephalosporins, quinolone-carboxylate gyrase inhibitors and phosphamide thiazine carbo

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC)

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Isophosphoramide Mustard and Its Mechanism of Bisalkylation.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Parathyroid Hormone-dependent Degradation of Type II Na /Pi Cotransporters

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport.

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Expression of Na/Pi cotransport from opossum kidney cells in Xenopus laevis oocytes

1 reference

https://api.crossref.org/works/10.1038/SJ.KI.5001803

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001803

1 reference

Dimensions Publication ID

17 June 2017

1018197179

0 references

Fatcat ID

release_cyvftuodnzcc3cm42uulbo6ida

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cyvftuodnzcc3cm42uulbo6ida

24 November 2022

mapped directly with Wikidata item

1 reference